Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Boston, Massachusetts
- Most recent report
- 10-Q, filed Aug 5, 2026
- Incorporated
- Delaware
- Filings on record
- 470 filings
- On EDGAR
- CIK 1689375
- Fiscal year ends
- December
- Filer status
- Accelerated filer, Smaller reporting company, Emerging growth company
Financials 8 of 22
News 8 of 50
Prospectuses and Registrations 8 of 14
- S-8 Registration statement for an employee plan Feb 26, 2026
- S-3 Shelf registration statement Nov 6, 2025
- S-8 Registration statement for an employee plan Mar 25, 2025
- S-8 Registration statement for an employee plan Feb 27, 2025
- 424B5 Prospectus supplement for an offering Jun 24, 2024
- S-8 Registration statement for an employee plan Mar 13, 2024
- 424B5 Prospectus supplement for an offering Sep 29, 2023
- S-8 Registration statement for an employee plan Mar 6, 2023
Proxies 8 of 13
- DEFA14A Extra proxy material Apr 29, 2026
- DEFA14A Extra proxy material Apr 24, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 24, 2026
- DEFA14A Extra proxy material Jun 3, 2025
- DEFA14A Extra proxy material Apr 25, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 25, 2025
- DEFA14A Extra proxy material Apr 29, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 29, 2024
Ownership 8 of 339
- 4 Insider reported a trade Sep 9, 2026
- 4 Insider reported a trade Sep 9, 2026
- 4 Insider reported a trade Sep 3, 2026
- 4 Insider reported a trade Sep 3, 2026
- 4 Insider reported a trade Sep 3, 2026
- 4 Insider reported a trade Sep 3, 2026
- 4 Insider reported a trade Sep 3, 2026
- 4 Insider reported a trade Sep 3, 2026
Other 8 of 32
- ARS Annual report sent to shareholders Apr 24, 2026
- EFFECT Notice that a registration became effective Dec 3, 2025
- CORRESP Reply to SEC staff Dec 1, 2025
- ARS Annual report sent to shareholders Apr 25, 2025
- ARS Annual report sent to shareholders Apr 29, 2024
- UPLOAD Comment letter from SEC staff Dec 20, 2023
- CORRESP Reply to SEC staff Dec 6, 2023
- UPLOAD Comment letter from SEC staff Nov 21, 2023
Everything here comes from Entrada Therapeutics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.